Prevention and drug therapy in chronic kidney disease

ESC CardioMed ◽  
2018 ◽  
pp. 993-999
Author(s):  
Stephan Segerer ◽  
Harald Seeger
Keyword(s):  
Risk Factors ◽  
Chronic Kidney Disease ◽  
Renal Function ◽  
Heart Disease ◽  
Drug Therapy ◽  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
Vascular Risk Factors ◽  
Function Loss

Three major goals need to be addressed in the treatment of patients with chronic kidney disease: (1) progression of renal function loss needs to be inhibited by treatment of risk factors, (2) co-morbidities and vascular risk factors have to be treated, and (3) the patient must be educated about and prepared for renal replacement therapy. During the progressive loss of renal function, the treatment necessities and medication doses need to be adjusted. Therefore, the treatment of heart disease differs between patients with normal and decreased renal function.

Renal disease

2018 ◽  
Author(s):  
Quentin Milner
Keyword(s):  
Chronic Kidney Disease ◽  
Renal Failure ◽  
Renal Function ◽  
Acute Renal Failure ◽  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Renal Disease ◽  
Replacement Therapy ◽  
Impaired Renal Function ◽  
Anaesthetic Management

This chapter describes the anaesthetic management of the patient with renal disease. The topics include estimation of renal function, chronic kidney disease, renal replacement therapy (including haemodialysis), acute renal failure, and the patient with a transplanted kidney. For each topic, preoperative investigation and optimization, treatment, and anaesthetic management are described. The effects of impaired renal function on the elimination of anaesthetic drugs are discussed.

Acute nephrotoxicity and neurotoxicity associated with concentrated star fruit juice consumption

2020 ◽  
Vol 13 (12) ◽  
pp. e234460
Author(s):  
Isolda Prado de Negreiros Nogueira Maduro ◽  
Alba Regina Jorge Brandão ◽  
Karla Cristina Petruccelli Israel
Keyword(s):  
Chronic Kidney Disease ◽  
Renal Function ◽  
Case Report ◽  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
Fruit Juice ◽  
Neurological Dysfunction ◽  
Star Fruit

Star fruit toxicity has been hugely described in patients with chronic kidney disease, either on conservative or renal replacement therapy. This is a case report of a man, without prior kidney or neurological dysfunction, who appeared to develop nephrotoxicity and neurotoxicity less than 12 hours after drinking concentrated star fruit juice (approximately 20 units of the fruit). He received timely renal replacement therapy and renal function fully recovered after discharge.

scholarly journals FP265ESTIMATION OF RENAL FUNCTION USING THE COCKROFT-GAULT FORMULA, CKD-EPI AND MDRD IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON RENAL REPLACEMENT THERAPY

2015 ◽  
Vol 30 (suppl_3) ◽  
pp. iii155-iii155
Author(s):  
Andreea Andronesi ◽  
Gener Ismail ◽  
Luminita Iliuta ◽  
Andreea Gamala ◽  
Sonia Balanica
Keyword(s):  
Chronic Kidney Disease ◽  
Renal Function ◽  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
Gault Formula

scholarly journals Peritonites in peritoneal dialysis patients

2018 ◽  
Author(s):  
Emanuelle Barbara Dias Tomaz ◽  
Plínio Trabasso ◽  
Gabriela Jorge Trigo Alves ◽  
Rodrigo Bueno de Oliveira
Keyword(s):  
Risk Factors ◽  
Chronic Kidney Disease ◽  
Peritoneal Dialysis ◽  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
Dialysis Patients ◽  
Fungal Peritonitis ◽  
Bacteria And Fungi ◽  
Etiological Agents

Peritonitis is one of the most common complications of the population with chronic kidney disease on peritoneal dialysis. The most frequent etiological agents are bacteria and fungi, the latter being responsible for 2 to 5% of the total cases of this type of infection. Fungal peritonitis is severe and its occurrence requires immediate removal of the catheter and transfer of renal replacement therapy for hemodialysis. The present study aimed to retrospectively study the risk factors and clinical outcomes of patients at the Centro Integrado de Nefrologia (CIN) of the Hospital das Clínicas da UNICAMP, who presented bacterial or fungal peritonitis, comparing them to peritoneal dialysis patients who did not present peritonitis.

Renal disease

2021 ◽  
pp. 191-200
Author(s):  
Quentin Milner
Keyword(s):  
Chronic Kidney Disease ◽  
Renal Failure ◽  
Renal Function ◽  
Acute Renal Failure ◽  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Renal Disease ◽  
Replacement Therapy ◽  
Impaired Renal Function ◽  
Anaesthetic Management

This chapter describes the anaesthetic management of the patient with renal disease. The topics include estimation of renal function; chronic kidney disease; renal replacement therapy (including haemodialysis); acute renal failure, and the patient with a transplanted kidney. For each topic, pre-operative investigation and optimisation, treatment, and anaesthetic management are described. The effects of impaired renal function on the elimination of anaesthetic drugs are discussed.

Renal disease

2016 ◽  
Author(s):  
Quentin Milner
Keyword(s):  
Chronic Kidney Disease ◽  
Renal Failure ◽  
Renal Function ◽  
Acute Renal Failure ◽  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Renal Disease ◽  
Replacement Therapy ◽  
Impaired Renal Function ◽  
Anaesthetic Management

This chapter describes the anaesthetic management of the patient with renal disease. The topics include estimation of renal function, chronic kidney disease, renal replacement therapy (including haemodialysis), acute renal failure, and the patient with a transplanted kidney. For each topic, preoperative investigation and optimization, treatment, and anaesthetic management are described. The effects of impaired renal function on the elimination of anaesthetic drugs are discussed.

scholarly journals Analysis of Prognostic Significance of Risk Factors for Development of Chronic Kidney Disease

2020 ◽  
Vol 6 (9) ◽  
pp. 167-173
Author(s):  
F. Babayev
Keyword(s):  
Risk Factors ◽  
Chronic Kidney Disease ◽  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
Prognostic Significance ◽  
Point Of View ◽  
Deficiency Anemia ◽  
Positive Trend ◽  
The Republic

Currently, more than two million people receive renal replacement therapy worldwide, but it is estimated that this is only 10% of patients in need. From this point of view, it is extremely important to increase caution about identifying risk factors and causes of chronic kidney disease in order to prevent it in a timely manner at the primary level. In Azerbaijan, an increase in patients on hemodialysis in dynamics was revealed. At the same time, both the number of hemodialysis centers and devices for hemodialysis increases. The number of dialysis machines from 2014 to 2019 tended to increase by +15.8% in 2015, +16.9% in 2016, +13.0% in 2017, +1.7% in 2018, +3.3% in 2019. The provision of patients with hemodialysis devices increased from 0.4 in 2014 to 0.7 per 10 thousand of the population in 2019. The positive trend in dialysis sessions received by patients in the republic was +16.7% in 2017, +12.1% in 2016, +5.4% in 2015, +1.3% in 2018, +0.3% in 2019. In the Javad-zade Republican Clinical Urological Hospital, an increase in dialysis sessions was noted in 2016 (+9.4%), 2016 (+9.4%) and 2017 (+5.2%). Identification of possible effects of risk factors for chronic kidney disease showed that in men, polycystic kidney disease had a statistically significant effect (RR=1.470, 95% CI 1.007–2.146), and in women, obesity (RR=3.366, 95% CI 2.286–4.954), iron deficiency anemia (RR=2.859, 95% CI 2,516–3,249). It is necessary to guarantee state financial support for renal replacement therapy for patients with chronic kidney disease, as well as state support for the development of dialysis centers.

Sign in / Sign up

Export Citation Format

Share Document